Clincosm LogoSign in Get a demo

Major Depressive Disorder

Showing NaN - NaN of 106
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD Trial in United States (REL-1017, Placebo)

Recruiting
  • Major Depressive Disorder
  • Saraland, Alabama
  • +46 more
Jan 18, 2023

MDD Trial in United States (REL-1017)

Recruiting
  • Major Depressive Disorder
  • Saraland, Alabama
  • +102 more
Jan 18, 2023

MDD Trial in Dallas (Drug: CVL-354, Drug: Placebo)

Active, not recruiting
  • Major Depressive Disorder
  • Drug: CVL-354
  • Drug: Placebo
  • Dallas, Texas
    Labcorp Drug Development
Jan 18, 2023

MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)

Completed
Has Results
  • Major Depressive Disorder
  • +2 more
  • AXS-05 (dextromethorphan and bupropion) oral tablets
  • Phoenix, Arizona
  • +50 more
Sep 16, 2022

MDD Trial in Dallas (Pregnenolone 500 mg, Pregnenolone 800 mg, Placebo)

Completed
  • Major Depressive Disorder
  • Pregnenolone 500 mg
  • +2 more
  • Dallas, Texas
    UT Southwestern Medical Center
Aug 29, 2022

MDD Trial in United States (XEN1101 10 mg, XEN1101 20 mg, Placebo)

Recruiting
  • Major Depressive Disorder
  • XEN1101 10 mg
  • +2 more
  • Lafayette, California
  • +5 more
Jul 11, 2022

Treatment Resistant Depression, MDD Trial in United States (AXS-05, Placebo)

Completed
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • Little Rock, Arkansas
  • +19 more
Jul 8, 2022

Anhedonia, MDD Trial in Puerto Rico, United States (Placebo, NBI-1065846)

Recruiting
  • Anhedonia
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +11 more
Jun 27, 2022

MDD, Menopause, Perimenopause Trial in Dallas (Pregnenolone, Placebo)

Recruiting
  • Major Depressive Disorder
  • +2 more
  • Dallas, Texas
    UT Southwestern Medical Center
Jun 28, 2022

Treatment Resistant Depression, MDD Trial in United States (AXS-05 (dextromethorphan-bupropion))

Completed
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • AXS-05 (dextromethorphan-bupropion)
  • Little Rock, Arkansas
  • +19 more
Jun 2, 2022

Chronic Kidney Diseases, MDD Trial in Dallas, Seattle (drug, behavioral, other)

Recruiting
  • Chronic Kidney Diseases
  • Major Depressive Disorder
  • Dallas, Texas
  • +2 more
May 27, 2022

MDD, Healthy Controls Trial in Dallas (Ketamine Hydrochloride, Midazolam injection)

Recruiting
  • Major Depressive Disorder
  • Healthy Controls
  • Ketamine Hydrochloride
  • Midazolam injection
  • Dallas, Texas
    UT Southwestern Medical Center
May 19, 2022

MDD Trial in United States (SP-624, Placebo)

Active, not recruiting
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +38 more
May 13, 2022

MDD Trial in Canada, United States (PNB01 fixed dose combination of pipamperone and citalopram, Citalopram, Pipamperone)

Completed
Has Results
  • Major Depressive Disorder
  • PNB01 fixed dose combination of pipamperone and citalopram
  • +2 more
  • Glendale, California
  • +30 more
Mar 14, 2022

MDD Trial in United States (Levomilnacipran ER, Fluoxetine, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Levomilnacipran ER
  • +2 more
  • Little Rock, Arkansas
  • +50 more
Mar 1, 2022

Asthma, MDD Trial in Dallas (Non-Interventional)

Completed
Has Results
  • Asthma
  • Major Depressive Disorder
  • Non-Interventional
  • Dallas, Texas
    University of Texas Southwestern Medical Center Psychoneuroendoc
Jan 24, 2022

MDD Trial in Atlanta, New York, Dallas (ALTO-300 PO Tablet)

Recruiting
  • Major Depressive Disorder
  • ALTO-300 PO Tablet
  • Atlanta, Georgia
  • +2 more
Feb 3, 2022

MDD Trial in Dallas (ALTO-300 PO tablet)

Recruiting
  • Major Depressive Disorder
  • ALTO-300 PO tablet
  • Dallas, Texas
    Site 102
Jan 3, 2022

MDD Trial in Dallas, Houston (Directional Deep Brain Stimulation)

Recruiting
  • Major Depressive Disorder
  • Directional Deep Brain Stimulation
  • Dallas, Texas
  • +1 more
Nov 24, 2021

MDD Trial in United States (SAGE-217, Placebo)

Terminated
  • Major Depressive Disorder
  • Bentonville, Arkansas
  • +45 more
Oct 15, 2021

Depression, MDD Trial in United States (AXS-05, Placebo)

Completed
  • Depression
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +42 more
Sep 22, 2021

Depressive Disorder, Depression, Depressive Disorder, Major Trial in United States (Synchronized Transcranial Magnetic

Completed
Has Results
  • Depressive Disorder
  • +4 more
  • Synchronized Transcranial Magnetic Stimulation (sTMS)
  • Sham Stimulation
  • La Jolla, California
  • +13 more
Aug 9, 2021

MDD Trial in Worldwide (SPD489 (Lisdexamfetamine dimesylate) + Antidepressant)

Terminated
Has Results
  • Major Depressive Disorder
  • SPD489 (Lisdexamfetamine dimesylate) + Antidepressant
  • Birmingham, Alabama
  • +211 more
Jun 9, 2021

MDD Trial in Worldwide (Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg, Antidepressant + SPD489 (Lisdexamfetamine

Completed
Has Results
  • Major Depressive Disorder
  • Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg
  • +4 more
  • Little Rock, Arkansas
  • +81 more
May 25, 2021

MDD Trial in United States (CP-601,927, Placebo)

Terminated
Has Results
  • Major Depressive Disorder
  • Little Rock, Arkansas
  • +57 more
Apr 7, 2021